iCAD, INC. (NASDAQ:ICAD) Files An 8-K Submission of Matters to a Vote of Security Holders

iCAD, INC. (NASDAQ:ICAD) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.

Story continues below

At the Company’s Annual Meeting of Stockholders held on November30, 2017, the stockholders of the Company entitled to vote at the meeting voted to (i)elect the nine individuals named below to serve as directors of the Company to hold office until the Annual Meeting of Stockholders to be held in 2018 and until their successors have been duly elected and qualified, (ii)approve, by non-binding advisory vote, the Company’s Say on Pay Vote and (iii)approve to ratify the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December31, 2017.

1) The votes cast by stockholders with respect to the election of directors were as follows:

NamesofNominees

NumberofVotesFor Number of VotesWithheld BrokerNon-Votes

Dr.Lawrence Howard

7,008,054 1,571,075 6,809,068

Kenneth Ferry

7,514,234 1,064,895 6,809,068

Dr.Rachel Brem

7,008,654 1,570,475 6,809,068

Anthony Ecock

7,514,534 1,064,595 6,809,068

Dr.Robert Goodman

7,514,544 1,064,585 6,809,068

Steven Rappaport

7,514,034 1,065,095 6,809,068

Andrew Sassine

8,229,408 349,721 6,809,068

Somu Subramaniam

7,005,144 1,573,985 6,809,068

Dr.Elliot Sussman

6,878,654 1,700,475 6,809,068
2) The votes cast by stockholders with respect to the non-binding advisory vote on executive officer compensation were as follows:

5,282,278 shares FOR the proposal, 3,278,464 shares AGAINST the proposal, 18,387 ABSTENTIONS and 6,809,068 BROKER NON-VOTES.

3) The votes cast by stockholders with respect to the ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December31, 2017 were as follows:

15,325,398 shares FOR the proposal, 48,144 shares AGAINST the proposal and 14,655 ABSTENTIONS.


About iCAD, INC. (NASDAQ:ICAD)

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. It operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. It develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

An ad to help with our costs